Switzerland reviews third anti-viral Covid vaccine
The race is on worldwide to provide the first Covid-19 vaccine
Copyright 2020 The Associated Press. All Rights Reserved.
The Swiss therapeutics products agency Swissmedic has started a review of another anti-Covid 19 vaccine – this time from United States biotech firm Moderna - in the rolling submission procedure.
This content was published on
2 minutes
Keystone-SDA/Swissmedic/SWI swissinfo.ch/ilj
This is the third authorisation procedure submitted in Switzerland for a vaccine against the novel coronavirus.
“The rolling submission procedure for mRNA-1273 is based on the initially submitted data packages on the preclinical situation and quality, as well as on preliminary clinical data. In a rolling review, the data can be evaluated as soon as they become available. The companies can then submit the latest data continuously without having to wait for the conclusive results from all studies,” Swissmedic said on FridayExternal link.
Swissmedic can thus obtain an initial picture of the benefit-risk profile of the vaccine candidates before the authorisation studies are completed (Phase III studies). This accelerates the review process while at the same time “preserving the same level of careful checking of all requirements relating to safety, efficacy and quality”, it explained.
The agency is already reviewing authorisation applications for Covid-19 vaccines from the companies AstraZeneca and Pfizer/BioNTech.
Vaccine strategy
On Wednesday Swiss government announced that it had earmarked an additional CHF100 million ($111 million) to buy an anti-Covid vaccine.
Interior Minister Alain Berset said the aim was to provide a “safe and efficient product of high-quality” for the population in Switzerland. The allocation of funds comes on top of CHF300 million approved earlier this year.
So far, Switzerland has assured reservations for about 13 million doses of prospective vaccines from AstraZeneca and Moderna and an international programme by the World Health OrganizationExternal link (WHO). It is also in negotiations with Pfizer/BioNTech about assuring delivery. Swissmedic has to examine and approve any product before it is distributed.
Health officials estimate about 60-70% of the population must be inoculated against the new coronavirus to get the pandemic under control.
Coronavirus infections in Switzerland rose by 6,739, the federal health authorities said on Friday. The death toll increased by 97.
More
More
Swiss stump up more cash to buy a Covid-19 vaccine
This content was published on
Interior Minister Alain Berset, who announced the news on Wednesday, said the aim was to provide a “safe and efficient product of high-quality” for the population in Switzerland. The allocation of funds comes on top of CHF300 million approved earlier this year. So far, Switzerland has assured reservations for about 13 million doses of prospective…
Swiss committee wants to end government resignations during legislative term
This content was published on
Members of the Federal Council should no longer be able to leave office before the end of their term, according to a House of Representatives committee.
Swiss government seat: Ritter and Pfister nominated to succeed Amherd
This content was published on
Markus Ritter from St Gallen and Martin Pfister from Zug were officially nominated by the Centre Party on Friday to succeed Defence Minister Viola Amherd.
Top Swiss court rejects Russian request for administrative tax assistance
This content was published on
There is currently no reason to transmit banking information to the Russian Federation, the Swiss Federal Court has ruled.
After strike by radiologists, doctors demonstrate in Bern
This content was published on
Following a strike by radiology technicians in Fribourg, doctors, vets, dentists and chiropractors expressed their frustration on Friday outside parliament in the Swiss capital.
Eurovision and bleak world situation are top themes at Basel carnival
This content was published on
The Eurovision Song Contest and the gloomy global situation are among the main themes of Basel Fasnacht (carnival) this year.
Prices of Swiss investment properties continue to rise despite stagnating rents
This content was published on
Although rents in Switzerland stagnated or fell in the final quarter of last year, prices for investment properties continued to rise. Both apartment buildings and office properties have become more expensive.
Probe into wrong Swiss pension figures clears federal office
This content was published on
Employees of the Swiss Federal Social Insurance Office (FSIO) did not breach their duty of care when calculating pension prospects, an investigation has concluded.
This content was published on
Hotels in the southern Swiss canton of Ticino welcomed significantly more guests last December than in the same month of the previous year.
This content was published on
The Swiss therapeutic products agency has begun reviewing another anti-Covid 19 vaccine in the rolling submission procedure.
This content was published on
Swiss drug authority Swissmedic has begun evaluating the so-called “Covid-19 Vaccine AstraZeneca”. It is the first time that a drugmaker has presented a coronavirus vaccine for approval in Switzerland.
You can find an overview of ongoing debates with our journalists here . Please join us!
If you want to start a conversation about a topic raised in this article or want to report factual errors, email us at english@swissinfo.ch.